Introduction {#s0005}
============

Skeletal muscles require dynamic changes in energy supply and oxygen flux for contraction, making it prone to reactive oxygen species (ROS)-mediated damage as a result of an increase in electron flux and leakage from the mitochondrial respiratory chain. Although physiological concentrations of ROS can function as signaling molecules that regulate proliferation, growth, differentiation, and apoptosis [@bib1], when ROS levels overcome the capacity of cellular antioxidant systems, they become toxic, introducing oxidative modifications on cellular macromolecules such as nucleic acids, lipids and, in particular, proteins, inflicting alterations to normal cellular functions. In skeletal muscle, oxidative stress state has negative consequences on action-potential conduction, excitation--contraction coupling, satellite cell differentiation, muscle contraction and mitochondrial respiration [@bib2].

Skeletal muscle ageing is associated with the gradual degenerative loss of skeletal muscle mass, quality, and strength, a condition known as sarcopenia. Oxidative stress contribute at least in part to muscle atrophy [@bib3; @bib4; @bib5; @bib6], and previous studies have addressed the extent of protein oxidative damage in the development of sarcopenia in mammalian models [@bib7; @bib8; @bib9; @bib10]. Although it is believed that oxidative stress contributes to skeletal muscle dysfunction through macromolecular damage, the molecular mechanisms remain elusive. Protein post-translational modifications induced by ROS are important features of oxidative stress [@bib11]. Among them, protein carbonyl content is by far the most commonly used marker of protein oxidation [@bib12; @bib13]. In fact, protein carbonylation occurs when proteins directly react with ROS, leading to the formation carbonyl groups (aldehydes and ketones) for instance on such amino acids side chains as arginine, lysine, threonine and proline. Introduction of carbonyl groups on proteins can also occur through the reaction of aldehydic products of lipid peroxidation and of dicarbonyl compounds upon glycation and glycoxidation. Since it often leads to a loss of protein function and an increased thermosensitivity or hydrophobicity of the targeted protein [@bib14; @bib15], protein carbonylation has been considered as an indicator of protein damage.

In human skeletal muscle, preliminary studies on *vastus lateralis* and external intercostal muscles have shown increased accumulation of protein carbonyls during ageing [@bib16; @bib17; @bib18; @bib19]. However, in most cases, the protein targets of these oxidative damages and their functional consequences have not been identified. Indeed, this is an essential step to get a complete view of protein oxidative modifications and to understand the mechanisms by which these oxidized proteins potentially contribute to muscle weakness and dysfunction during ageing.

Therefore, proteomic studies, including the analysis of protein abundance as well as protein carbonylation are expected to provide valuable information to unravel the key molecular pathways implicated. In fact, proteomics and in particular bi-dimensional (2D) gels represent appropriate tools for the detection and identification of specific carbonylated proteins in a complex mixture [@bib2; @bib13; @bib20]. The identification of such oxidatively modified proteins (i.e. the oxi-proteome components), can give some insights into the mechanisms by which these damaged proteins accumulate and potentially affect cellular and/or tissular function during ageing or in disease conditions [@bib21]. In this paper, the occurrence and characterization of carbonylated proteins was studied in human *rectus abdominis* muscle obtained from young and old healthy donors. Although no significant differences in global protein carbonylation was observed at the proteome level, we have used 2D gel electrophoresis based proteomic approaches to improve the resolution of individual proteins for the quantitative analysis of their carbonylation status and further identification of these major skeletal muscle proteins that are targeted by oxidative damage during human *rectus abdominis* skeletal muscle ageing.

Material and methods {#s0010}
====================

Human biopsies {#s0015}
--------------

Human *rectus abdominis* muscle biopsies were obtained during surgery. Each biopsy used has the written consent of the volunteer donor. A total of 22 human muscle biopsies were used: 11 from healthy men individuals between 0 to 12 years old (named young samples) and 11 from healthy men individuals between 52 and 76 years old (named old samples) ([Table 1](#t0005){ref-type="table"}). All muscle biopsies had an initial wet weight between 15 and 24 mg ([Table 1](#t0005){ref-type="table"}). The study was approved by the Ethical Committee at the Uppsala University Hospital.

Protein extraction for proteomics analyses {#s0020}
------------------------------------------

Proteins extracts from skeletal muscle biopsies were obtained by physical disruption of the sample biopsies using a ULTRA-TURRAX® T25 (IKA®) at 4 °C in a lysis buffer containing 10 mM Tris--HCl (pH 7.4), 8 M urea, 2 M thiourea, 4% CHAPS and 20 mM DTT. After incubation on ice for 20 min, soluble proteins were recovered after clarification by centrifugation for 40 min at 21,000 g. Proteins were further precipitated using the 2D clean-up kit (GE Healthcare) and the resulting pellet was re-suspended into the same lysis buffer. Protein concentrations were determined by the Bradford Method [@bib22] using the Bio-Rad Protein Kit Assay (Bio-Rad).

Protein carbonyl immunodetection after derivatization with DNPH {#s0025}
---------------------------------------------------------------

Carbonylated proteins were derivatized with 2,4-dinitrophenylhydrazine (DNPH) to form 2--4-dinitrophenylhydrazone (DNP) proteins adducts [@bib23]. For total carbonyl quantification, equal quantities of proteins were loaded and separated by SDS-PAGE 12% (v/v). Chemicals for SDS-PAGE were purchased from Bio-Rad. All other chemicals were of analytical grade and obtained from Sigma-Aldrich. For the detection of carbonylated proteins, gels were electrotransferred onto Hybond-C nitrocellulose membranes (GE Healthcare) and incubated with anti-DNP antibodies (1:5000, Sigma-Aldrich). Carbonylated proteins were revealed by a fluorescent anti-rabbit IgG 800CW (1:15,000) polyclonal antibody (LI-COR). Densitometry analyses were performed using NIH ImageJ software and the data are expressed as % volume in pixels.

For 2D gel electrophoresis, derivatization of proteins carbonyls was achieved on IPG strips after isoelectric focusing (IEF), with a 10 mM DNPH, 2 M HCl solution at room temperature (RT) as described previously [@bib24]. 500 µg of protein were diluted on a rehydratation buffer (7 M urea, 2 M thiourea, 1% Amberlite, 4% CHAPS, 1.2% Destreak (GE Healthcare), 0.5% Pharmalyte pH 3--10 (GE Healthcare)) and loaded into 13 cm IPG strips pH 3--10 NL (GE Healthcare). Gel rehydration of the IPG strips was done overnight at RT in an Immobiline DryStrip rewelling tray. IEF was performed using an Ettan™ IPGphor™ 3 Isoelectric Focusing System (GE Healthcare) at 20 °C using the following electrical profile: step, 150 V for 11 h; grad, 1000 V for 3 h; grad, 8000 V for 2 h; step, 8000 V for 1 h. Neutralization step after derivatization with DNPH was performed with 2 M Trizma-Base containing 30% of glycerol (GE Healthcare). Before SDS-PAGE, all IPG strips were equilibrated with a 6 M urea, 10% SDS and 30% Glycerol (GE Healthcare), 0.5 M Tris--HCl (pH 8.8) solution for 2 steps of 15 min: the first one with equilibration solution containing 1% DTT and the second with equilibration solution containing 3% iodoacetamide. SDS-PAGE was carried out using the Protean II system (Bio-Rad). For each sample, two 12% (v/v) polyacrylamide gels were performed in parallel: one for total protein stains with Coomassie Brilliant Blue G-250 (Bio-Rad) for further mass spectrometry analysis; and the other with derivatized protein residues for electrotransfer onto nitrocellulose membranes, where total amount of proteins were stained by a Fast Green solution (Sigma-Aldrich) prior to antibodies incubation for loading control. Membranes were then blocked with Odyssey blocking buffer (LI-COR) overnight at 4 °C. Primary anti-DNP antibodies (1:5000, Sigma-Aldrich) were incubated for 1 h at RT. Revelation was done by a fluorescent anti-rabbit IgG 800CW (1:15,000) polyclonal antibody (LI-COR). Washing steps were done with a PBS/0.1% Tween solution. Carbonylated proteins were revealed by the Odyssey Infrared Imaging System (LI-COR).

Proteomics data acquisition and analysis {#s0030}
----------------------------------------

Spot detection and quantification were carried out using the image Master 2D Platinum 7 software (GE Healthcare). For comparison, we used the data expressed as spot % volume (%vol) in pixels, which corresponds to a normalized value of the spot volume by considering the total volume of all the spots present in the membrane [@bib25]. To take into account the total amount of loaded protein in each IPG strip, we defined a %vol per carbonylated spot (*N*%vol) by normalizing the %vol of each anti-DNP incubated membrane with its corresponding %vol on the Fast Green-stationed membrane. The relative modification index ratio (RMI ratio) was obtained by dividing the *N*%vol of the old group of samples by the *N*%vol of the young one.

In-gel digestion and mass spectrometry {#s0035}
--------------------------------------

Spots of interest were manually excised from Coomassie Blue stained 12% (v/v) polyacrylamide gels and were automatically in-gel digested by trypsin [@bib26] using a robot Freedom EVO 100 digester/spotter robot (Tecan). Resulted peptides were then desalted for mass spectrometry (MS/MS) analysis. Results obtained were subjected to a search on the SwissProt database using the MASCOT software (Matrix Science Ltd., London, UK). The software compares the MASCOT peptide sequences derived from spectra with those in libraries for protein identification. Search parameters were as follows: database, SwissProt; taxonomy, all entries or mammalian; enzyme, trypsin; allow up to one missed cleavage; fixed modifications, none; variable modifications, methionine oxidation; peptide mass tolerance, 70 ppm; and fragment mass tolerance, 500 ppm.

Results and discussion {#s0040}
======================

Initial screening looking at changes at the global proteome level of carbonylated proteins was performed after derivatization of protein carbonyls with DNPH followed by immunodetection of DNP protein adducts after SDS-PAGE ([Fig. 1](#f0005){ref-type="fig"}A). Densitometry analysis was performed and normalized by total protein content for each sample ([Fig. 1](#f0005){ref-type="fig"}B and C). No significant differences at the global level in protein carbonyl content was detected between groups, in agreement with what was previously reported by Marzani et al. who did not find a statistical difference on protein carbonyl content during ageing in both *rectus abdominis* and *vastus lateralis* human muscles [@bib18]. More recently, Fanò et al., using skeletal muscle biopsy samples obtained from *vastus lateralis*, found that protein carbonyls, showed a significant increase during ageing. However, this difference was not significant after splitting by gender [@bib27]. Importantly, immunodetection of carbonylated proteins after one-dimensional (1D) electrophoresis separation has serious limitations for the resolution of single protein bands and can provide only restricted information.

To further analyze the occurrence of protein carbonylation at the single protein level, 2D gel electrophoresis separation of protein extracts was performed prior to immunodetection of carbonylated proteins. 2D gels are very appropriate to investigate protein isoforms since many post-translational modifications (such as carbonylation of arginine or lysine residues) often leads to changes in the isoelectric point of proteins, and thus shift the position of the protein in 2D gels. After electrotransfer onto nitrocellulose membranes total protein profiles were obtained by fast-green staining ([Fig. 2](#f0010){ref-type="fig"}). All the analyzed samples displayed a similar protein migration pattern, suggesting no drastic shifts in the protein profiles at the expression level ([Fig. 2](#f0010){ref-type="fig"}, right panels) between the two experimental groups. Immunodetection of carbonylated proteins was performed after their derivatization by DNPH as described in Material and methods. Interestingly, the pattern of the modified proteins was not superimposable with the pattern obtained for the total protein staining, indicating that certain proteins represent preferential targets for these deleterious oxidative modifications. Several proteins of high molecular weight were found preferentially carbonylated ([Fig. 2](#f0010){ref-type="fig"}, left panel) while certain proteins with an isoelectric point higher than 5, also appeared to be preferentially carbonylated.

A relative modification index (RMI) per spot was calculated in order to evidence differentially carbonylated proteins between the two experimental groups taking into account their protein expression levels. Seventeen protein spots exhibited an RMI ratio consistently higher than 1.3 (increasingly carbonylated) in all biopsies from the aged group as compared with the young one. On the other hand, fourteen protein spots showed decreased carbonylation in the old group (RMI\<0.7). Protein spots evidenced as increasingly carbonylated were excised from Coomassie Blue stained 2D gels ([Fig. 3](#f0015){ref-type="fig"}) and analyzed by MS/MS for protein identification. Protein spots that were identified in the aged group are listed in [Table 2](#t0010){ref-type="table"}. Among the identified proteins, 8 are muscle specific, 4 are ubiquitous in different tissues and organ systems, and 2 proteins belong from plasma ([Table 2](#t0010){ref-type="table"}).

The identified skeletal muscle proteins were then analyzed and grouped by metabolic pathways and cellular functions. Major biological functions include muscle contraction, energy transduction and energy metabolism ([Fig. 4](#f0020){ref-type="fig"}). Among proteins involved in muscle contraction, we have found that myosin 7, troponin T, myosin-binding protein C (MyBPC), and LIM domain-binding protein 3 (ZASP) are increasingly carbonylated in aged muscle. Interestingly, the decreased speed of contraction observed in old age at both the muscle and motor protein levels is a hallmark of skeletal muscle ageing [@bib28; @bib29; @bib30; @bib31]. Myosin is a highly conserved protein that converts chemical energy into mechanical force and a key protein for muscle contraction. Previous studies have shown increased glycation of myosin in both fiber types of aged rats [@bib32]. In addition, the carbonylated residues have been identified [@bib33]. Interactions of myosin with cytoskeletal proteins such as titin, myomesin/M protein and MyBPC play an important role in thick filaments physiology. MyBPC contributes to the assembly and stabilization of thick filaments and modulates the formation of actomyosin cross-bridges, via direct interactions with both thick myosin and thin actin filaments [@bib34; @bib35]. The importance of MyBPC to muscle contraction is further emphasized by the discovery that mutations in genes encoding MyBPC cause myopathies in both skeletal [@bib36; @bib37] and cardiac muscles [@bib38; @bib39; @bib40]. Increased oxidation of MyBPC, together with the previously reported age-dependent decrease of myosin isoforms and regulatory proteins like myosin binding proteins C and H [@bib41; @bib42; @bib43; @bib44], may contribute to the destabilization of muscle fibers. In addition, perturbations in the thin sarcomere fillaments of muscle fibers have also been associated with differently expression of actin and its regulatory proteins such as troponin and tropomyosin [@bib42; @bib43; @bib45; @bib46]. Here we found increased carbonylation levels of troponin T in the elderly. Troponin inhibits the actomyosin Mg^2+^-ATPase and the Ca^2+^ release from the sarcoplasmic reticulum inducing a change in the troponin--tropomyosin conformation that exposes myosin binding sites on the actin filament and activates the myosin ATPase, thereby allowing muscle contraction [@bib47; @bib48]. Since muscle contraction depends on myofibrillar thin filament interactions [@bib49], the oxidative damage to these proteins may well compromise this interaction and hence muscle contraction.

The motor functions of striated muscle crucially depend on the highly ordered arrays of thick myosin and thin actin filaments in sarcomeres. Although its detailed role has not been elucidated yet, the LIM domain-binding protein 3 (ZASP), found as increasingly carbonylated in aged *rectus abdominis* muscle, functions as an adapter to couple protein kinase C-mediated signaling to the cytoskeleton and to maintain Z-disc stability as well as cytoskeletal ultrastructure during contraction. Accumulation of this protein in its oxidized form may lead to protein aggregates formation and myofibril disintegration that may result in muscle weakness.

Muscle contraction depends also in high-energy fluxes where creatine kinase plays a central role. During muscle contraction, myosin hydrolyzes ATP into ADP upon filament sliding. The renewal of ATP is achieved mainly by the phosphocreatine--creatine kinase (PCr--CK) system. Among the creatine kinase (CK) isoenzymes, the muscle-type CK (MM-CK) specifically binds to the myofibril M-line and is associated with the action-activated myosin ATPase as an intramyofibrillar ATP regenerator [@bib50; @bib51; @bib52]. Since this MM-CK was found irreversibly oxidized in old *rectus abdominis* muscle, this could alter muscle metabolism and compromise muscle contraction in the elderly. Besides the PCr--CK system, the glycolytic network and its closer interaction between mitochondria and organelles also provide energy within muscle cells [@bib53]. In this study, 3 glycolytic enzymes appear as highly carbonylated in old slow oxidative skeletal *rectus abdominis* muscle: the fructose-bisphosphate aldolase A, the glycerol-3-phosphate dehydrogenase (GPD1) and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ([Table 2](#t0010){ref-type="table"}). Interestingly, several of these enzymes involved in anaerobic metabolism have been found decreased with age in murine and human skeletal muscle [@bib54; @bib55].

Although slow skeletal muscles uses mainly oxidative mitochondrial processes to generate the levels of ATP needed to maintain contractile activity for long time without showing fatigue [@bib53], they also rely in glycolysis for their energy production [@bib56]. For this reason, muscle metabolism and contraction in aged skeletal muscle would be affected by irreversible carbonylation on glycolytic proteins, as previously reported in certain diseases when these glycolytic enzymes are not functional [@bib57; @bib58; @bib59; @bib60; @bib61; @bib62]. Defects in the muscle form of glycogen phosphorylase, another protein found increased carbonylated in old *rectus abdominis* muscle, are involved in type 5 glycogen storage disease, also known as McArdle disease, a myopathy also characterized by exercise intolerance, such as easy fatigability, muscle cramps and contractures as well as muscle weakness [@bib63; @bib64]. Intramuscular glycogen acts as a readily available source of glucose-6-phosphate for glycolysis within skeletal muscle and glycogen phosphorylase catalyses the rate-limiting step in glycogenolysis [@bib65]. Therefore, a deficiency in glycogen phosphorylase may result in the inability to mobilize muscle glycogen during anaerobic metabolism [@bib66].

Although it is well recognized that ageing causes changes in the proteome, the nature and targets of these changes, their consequences on skeletal muscle function and how they may contribute to sarcopenia have not yet been completely elucidated. Our results suggest that oxidative stress during skeletal muscle ageing targets the contractile machinery, but also structural and regulatory proteins. In addition, the main mechanism of energy production, the phosphocreatine kinase system was affected by carbonylation in the elderly while other energetic metabolic pathways such as glycolysis appear to be also affected. Finally, the heat shock 70 kDa protein (HSP70), a key player in protein quality control with different identified roles in skeletal muscle [@bib67], such as protection against oxidative stress, was also found highly carbonylated in old skeletal muscle. Up-regulation of heat shock proteins is a well know feature of muscle ageing [@bib46; @bib68; @bib69]. Further studies should address the functional status of the identified carbonylated proteins and related cellular pathways associated with muscle dysfunction in order to reveal their role in the development of the ageing phenotype.
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![Analysis of total carbonylated proteins of human *rectus abdominis* muscle biopsies. (A) Carbonylated protein profiles from young and old human biopsies after 1D gel electrophoresis. Protein carbonyl were detected by Western-blotting against protein-DNP derivatives and monitored by fluorescent secondary antibody hybridation. (B) Total protein profiles stained with colloidal Coomassie brilliant blue G after 1D gel electrophoresis. (C) Densitometric analysis of carbonylated protein western-blots. Semi-quantitative assessment of modified proteins was done using total protein staining for normalization. Relative values are expressed as mean±S.D. (*n*=11) and no significant difference was found between the young and old groups.](gr1){#f0005}

![Oxi-proteome analysis of young and old human skeletal muscle samples. Protein extracts from young (*n*=3) and old (*n*=3) human skeletal muscle biopsies were separated by 2D gel electrophoresis. After the second dimension, gels were electrotransferred onto nitrocellulose membranes for subsequent immune detection of DPNH-derivatized carbonylated proteins (left panels). Densitometry analysis was done by image Master 2D software (GE Healthcare) using total protein staining (right panels) as loading control.](gr2){#f0010}

![Coomassie blue staining of one representative 2D gel. The numbers and positions of the 17 selected spots identified by MS/MS correspond to those found as consistently increased on the old group (RMI\>1.3).](gr3){#f0015}

![Functional grouping of muscle proteins increasingly oxidized with age. Increasingly oxidized muscle-specific proteins identified in aged *rectus abdominis* biopsies were grouped in three functional categories: muscle contraction, energy metabolism and energy transduction.](gr4){#f0020}

###### 

Characteristics of the samples biopsies.

  Sample no   Donor age (years)   Wet weight (mg)   Protein recovery ratio (w/w in %)[a](#ngtbl1.1){ref-type="table-fn"}
  ----------- ------------------- ----------------- ----------------------------------------------------------------------
  1           0                   24.00             7.0
  2           1                   20.80             4.3
  3           5                   20.00             7.6
  4           9                   17.00             9.3
  5           6.5                 15.00             7.1
  6           10.75               21.90             7.6
  7           12                  22.00             9.1
  8           7.1                 22.00             9.7
  9           76                  20.30             9.5
  10          70                  18.00             8.3
  11          74                  19.10             7.8
  12          66                  19.60             8.0
  13          74                  19.20             8.4
  14          65                  18.66             5.2
  15          65                  18.78             6.6
  16          71                  24.00             10.8
  17          12                  20.00             15.6
  18          3                   20.50             3.6
  19          9                   20.38             11.0
  20          56                  20.47             7.4
  21          61                  20.53             17.1
  22          52                  20.13             27.2

Protein recovery ratio corresponds to the protein amount in mass / biopsy mass.

###### 

Localization of carbonylated proteins identified from old skeletal muscle biopsies.

  **Protein name and localization**                                   **Swiss-Prot accession no**   **Protein spot no**[a](#ngtbl2.1){ref-type="table-fn"}   **Mascot score**[b](#ngtbl2.2){ref-type="table-fn"}   **Sequence coverage (%)**   **No. of sequenced peptides**   **Theoretical protein mass (kDa)**   **Theoretical PI**   **RMI ratio**[c](#ngtbl2.3){ref-type="table-fn"}
  ------------------------------------------------------------------- ----------------------------- -------------------------------------------------------- ----------------------------------------------------- --------------------------- ------------------------------- ------------------------------------ -------------------- --------------------------------------------------
  **Ubiquitous proteins:**                                                                                                                                                                                                                                                                                                               
  Collagen alpha-1(VI) chain                                          CO6A1_HUMAN                   1                                                        205                                                   7                           5                               108                                  5.3                  4.34
  Heat shock cognate 71 kDa protein                                   HSP7C_HUMAN                   5                                                        256                                                   15                          5                               71                                   5.4                  1.63
  Glycerol-3-phosphate dehydrogenase \[NAD^+^\], cytoplasmic (GPD1)   GPDA_HUMAN                    13                                                       214                                                   22                          4                               38                                   5.8                  1.52
  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)                    G3P_HUMAN                     14                                                       243                                                   12                          3                               36                                   8.6                  1.67
  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)                    G3P_HUMAN                     15                                                       424                                                   25                          5                               36                                   8.6                  1.68
  Voltage-dependent anion-selective channel protein 1                 VDAC1_HUMAN                   16                                                       685                                                   39                          8                               31                                   8.6                  1.88
                                                                                                                                                                                                                                                                                                                                           
  **Muscle specific proteins:**                                                                                                                                                                                                                                                                                                          
  Myosin-binding protein C, slow-type (MyBPC)                         MYPC1_HUMAN                   2                                                        119                                                   3                           3                               128                                  5.8                  1.54
  Glycogen phosphorylase, muscle form                                 PYGM_HUMAN                    3                                                        882                                                   22                          13                              97                                   6.6                  1.67
  Myosin-7                                                            MYH7_HUMAN                    7                                                        63                                                    --                          1                               223                                  5.6                  3.12
  Creatine kinase M-type                                              KCRM_HUMAN                    8                                                        206                                                   9                           3                               43                                   6.8                  1.44
  Creatine kinase M-type                                              KCRM_HUMAN                    9                                                        416                                                   20                          6                               43                                   6.8                  1.54
  Fructose-bisphosphate aldolase A                                    ALDOA_HUMAN                   10                                                       611                                                   31                          7                               39                                   8.3                  1.65
  Troponin T, slow skeletal muscle                                    TNNT1_HUMAN                   11                                                       512                                                   22                          6                               33                                   5.9                  1.87
  Troponin T, slow skeletal muscle                                    TNNT1_HUMAN                   12                                                       244                                                   22                          5                               33                                   5.9                  1.42
  LIM domain-binding protein 3 (ZASP)                                 LDB3_HUMAN                    17                                                       206                                                   8                           4                               77                                   8.5                  1.70
                                                                                                                                                                                                                                                                                                                                           
  **Plasma proteins:**                                                                                                                                                                                                                                                                                                                   
  Serotransferrin                                                     TRFE_HUMAN                    4                                                        399                                                   17                          10                              77                                   6.8                  1.31
  Serum albumin                                                       ALBU_HUMAN                    6                                                        986                                                   29                          13                              69                                   5.9                  1.33

Spots of interest were identiﬁed by MALDI-TO--FTOF-MS as described under Material and methods. For each spot, different parameters clarifying protein identification by MS are indicated.

Protein spot number refers to the numbered spots in [Fig. 3](#f0015){ref-type="fig"}.

Mascot protein scores greater than 56 are significant (*P*\<0.05).

RMI ratio represents the Relative Modification Index ratio.
